76 related articles for article (PubMed ID: 20142791)
1. Ovariectomy in aged versus young rats augments matrix metalloproteinase-mediated vasoconstriction in mesenteric arteries.
Lekontseva ON; Rueda-Clausen CF; Morton JS; Davidge ST
Menopause; 2010; 17(3):516-23. PubMed ID: 20142791
[TBL] [Abstract][Full Text] [Related]
2. Estrogen replacement increases matrix metalloproteinase contribution to vasoconstriction in a rat model of menopause.
Lekontseva O; Jiang Y; Davidge ST
J Hypertens; 2009 Aug; 27(8):1602-8. PubMed ID: 19412129
[TBL] [Abstract][Full Text] [Related]
3. Ovariectomy, but not estrogen deficiency, increases CYP4A modulation of alpha(1)-adrenergic vasoconstriction in aging female rats.
Berezan DJ; Xu Y; Falck JR; Kundu AP; Davidge ST
Am J Hypertens; 2008 Jun; 21(6):685-90. PubMed ID: 18437124
[TBL] [Abstract][Full Text] [Related]
4. Aging increases cytochrome P450 4A modulation of alpha1-adrenergic vasoconstriction in mesenteric arteries.
Berezan DJ; Dunn KM; Falck JR; Davidge ST
J Cardiovasc Pharmacol; 2008 Mar; 51(3):327-30. PubMed ID: 18356699
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase enhances big-endothelin-1 constriction in mesenteric vessels of pregnant rats with reduced uterine blood flow.
Abdalvand A; Morton JS; Bourque SL; Quon AL; Davidge ST
Hypertension; 2013 Feb; 61(2):488-93. PubMed ID: 23297376
[TBL] [Abstract][Full Text] [Related]
6. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury.
Mountain DJ; Freeman MB; Kirkpatrick SS; Cook RB; Chalk JE; Stevens SL; Goldman MH; Grandas OH
Ann Vasc Surg; 2013 Apr; 27(3):337-45. PubMed ID: 23088810
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats.
Wong CM; Yao X; Au CL; Tsang SY; Fung KP; Laher I; Vanhoutte PM; Huang Y
Vascul Pharmacol; 2006 May; 44(5):290-8. PubMed ID: 16542882
[TBL] [Abstract][Full Text] [Related]
8. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen and estrogen attenuate enhanced vascular reactivity induced by estrogen deficiency in rat carotid arteries.
Tsang SY; Yao X; Chan HY; Chan FL; Leung CS; Yung LM; Au CL; Chen ZY; Laher I; Huang Y
Biochem Pharmacol; 2007 May; 73(9):1330-9. PubMed ID: 17250811
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in the effect of age on electrical field stimulation (EFS)-induced adrenergic vasoconstriction in rat mesenteric resistance arteries.
Sullivan JC; Davison CA
J Pharmacol Exp Ther; 2001 Mar; 296(3):782-8. PubMed ID: 11181907
[TBL] [Abstract][Full Text] [Related]
12. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes.
He S; Prasanna G; Yorio T
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3737-45. PubMed ID: 17652746
[TBL] [Abstract][Full Text] [Related]
14. Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1.
Sachidanandam K; Harris A; Hutchinson J; Ergul A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1016-21. PubMed ID: 16741041
[TBL] [Abstract][Full Text] [Related]
15. Effects of ovariectomy and resistance training on MMP-2 activity in rat calcaneal tendon.
Pereira GB; Prestes J; Leite RD; Magosso RF; Peixoto FS; Marqueti Rde C; Shiguemoto GE; Selistre-de-Araújo HS; Baldissera V; Perez SE
Connect Tissue Res; 2010 Dec; 51(6):459-66. PubMed ID: 20388014
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
[TBL] [Abstract][Full Text] [Related]
17. Estrogen alters relative contributions of nitric oxide and cyclooxygenase products to endothelium-dependent vasodilation.
Case J; Davison CA
J Pharmacol Exp Ther; 1999 Nov; 291(2):524-30. PubMed ID: 10525067
[TBL] [Abstract][Full Text] [Related]
18. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor.
Fernandez-Patron C; Radomski MW; Davidge ST
Circ Res; 1999 Nov; 85(10):906-11. PubMed ID: 10559137
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent limitation of arterial enlargement by the matrix metalloproteinase inhibitor RS-113,456.
Karwowski JK; Markezich A; Whitson J; Abbruzzese TA; Zarins CK; Dalman RL
J Surg Res; 1999 Nov; 87(1):122-9. PubMed ID: 10527713
[TBL] [Abstract][Full Text] [Related]
20. Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats.
Lam KK; Lee YM; Hsiao G; Chen SY; Yen MH
Menopause; 2006; 13(2):294-302. PubMed ID: 16645543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
